Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Hyaluronic Acid-Decorated Liposomes as Innovative Targeted Delivery System for Lung Fibrotic Cells.

Pandolfi L, Frangipane V, Bocca C, Marengo A, Tarro Genta E, Bozzini S, Morosini M, D'Amato M, Vitulo S, Monti M, Comolli G, Scupoli MT, Fattal E, Arpicco S, Meloni F.

Molecules. 2019 Sep 10;24(18). pii: E3291. doi: 10.3390/molecules24183291.

2.

Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis.

Codullo V, Cova E, Pandolfi L, Breda S, Morosini M, Frangipane V, Malatesta M, Calderan L, Cagnone M, Pacini C, Cavagna L, Recalde H, Distler JHW, Giustra M, Prosperi D, Colombo M, Meloni F, Montecucco C.

J Control Release. 2019 Aug 17;310:198-208. doi: 10.1016/j.jconrel.2019.08.015. [Epub ahead of print]

PMID:
31430501
3.

Mechanisms of action and antimicrobial activity of ceftobiprole.

Morosini MI, Díez-Aguilar M, Cantón R.

Rev Esp Quimioter. 2019 Sep;32 Suppl 3:3-10. Review.

4.

Hypermucoviscous Klebsiella pneumoniae: A challenge in community acquired infection.

Sánchez-López J, García-Caballero A, Navarro-San Francisco C, Quereda C, Ruiz-Garbajosa P, Navas E, Dronda F, Morosini MI, Cantón R, Diez-Aguilar M.

IDCases. 2019 May 3;17:e00547. doi: 10.1016/j.idcr.2019.e00547. eCollection 2019.

5.

Outbreak of NDM-1+CTX-M-15+DHA-1-producing Klebsiella pneumoniae high-risk clone in Spain owing to an undetectable colonised patient from Pakistan.

Hernández-García M, Pérez-Viso B, León-Sampedro R, Navarro-San Francisco C, López-Fresneña N, Díaz-Agero C, Morosini MI, Ruiz-Garbajosa P, Cantón R.

Int J Antimicrob Agents. 2019 Aug;54(2):233-239. doi: 10.1016/j.ijantimicag.2019.05.021. Epub 2019 Jun 4.

PMID:
31173865
6.

Whole-genome sequencing reveals nosocomial Clostridioides difficile transmission and a previously unsuspected epidemic scenario.

García-Fernández S, Frentrup M, Steglich M, Gonzaga A, Cobo M, López-Fresneña N, Cobo J, Morosini MI, Cantón R, Del Campo R, Nübel U.

Sci Rep. 2019 May 6;9(1):6959. doi: 10.1038/s41598-019-43464-4.

7.

Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems.

Cantón R, Oliver A, Alós JI, de Benito N, Bou G, Campos J, Calvo J, Canut A, Castillo J, Cercenado E, Domínguez MÁ, Fernández-Cuenca F, Guinea J, Larrosa N, Liñares J, López-Cerero L, López-Navas A, Marco F, Mirelis B, Moreno-Romo MÁ, Morosini MI, Navarro F, Oteo J, Pascual Á, Pérez-Trallero E, Pérez-Vázquez M, Soriano A, Torres C, Vila J, Martínez-Martínez L.

Enferm Infecc Microbiol Clin. 2019 Mar 13. pii: S0213-005X(19)30135-1. doi: 10.1016/j.eimc.2019.01.017. [Epub ahead of print] Review. English, Spanish.

PMID:
30878313
8.

Urinary tract infections and antimicrobial resistance.

Morosini MI, Del Campo R.

Rev Clin Esp. 2019 Apr;219(3):149-150. doi: 10.1016/j.rce.2018.12.003. Epub 2019 Mar 4. English, Spanish. No abstract available.

PMID:
30846185
9.

Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study.

Cova E, Pandolfi L, Colombo M, Frangipane V, Inghilleri S, Morosini M, Mrakic-Sposta S, Moretti S, Monti M, Pignochino Y, Benvenuti S, Prosperi D, Stella G, Morbini P, Meloni F.

Int J Nanomedicine. 2019 Jan 23;14:773-785. doi: 10.2147/IJN.S186344. eCollection 2019.

10.

Direct antimicrobial susceptibility testing from the blood culture pellet obtained for MALDI-TOF identification of Enterobacterales and Pseudomonas aeruginosa.

López-Pintor JM, Navarro-San Francisco C, Sánchez-López J, García-Caballero A, Loza Fernández de Bobadilla E, Morosini MI, Cantón R.

Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1095-1104. doi: 10.1007/s10096-019-03498-y. Epub 2019 Feb 2.

PMID:
30712228
11.

Impact of De-escalation on Prognosis of Patients With Bacteremia due to Enterobacteriaceae: A Post Hoc Analysis From a Multicenter Prospective Cohort.

Palacios-Baena ZR, Delgado-Valverde M, Valiente Méndez A, Almirante B, Gómez-Zorrilla S, Borrell N, Corzo JE, Gurguí M, De la Calle C, García-Álvarez L, Ramos L, Gozalo M, Morosini MI, Molina J, Causse M, Pascual Á, Rodríguez-Baño J; REIPI/GEIRAS-SEIMC Bacteraemia-MIC Group .

Clin Infect Dis. 2019 Aug 30;69(6):956-962. doi: 10.1093/cid/ciy1032.

PMID:
30535051
12.

Early prosthetic endocarditis caused by Stenotrophomonas maltophilia.

Morte E, Tolmos M, Halperin A, Morosini MI, Cantón R, Hermida JM.

Med Mal Infect. 2018 Dec;48(8):543-546. doi: 10.1016/j.medmal.2018.09.004. Epub 2018 Oct 15. No abstract available.

PMID:
30336969
13.

Emergence and dissemination of colistin-resistant Klebsiella pneumoniae isolates expressing OXA-48 plus CTX-M-15 in patients not previously treated with colistin in a Spanish university hospital.

Barragán-Prada H, Ruiz-Hueso P, Tedim AP, González-Candelas F, Galán JC, Cantón R, Morosini MI.

Diagn Microbiol Infect Dis. 2019 Feb;93(2):147-153. doi: 10.1016/j.diagmicrobio.2018.08.014. Epub 2018 Sep 8.

PMID:
30266401
14.

Antimicrobial susceptibility of non-fermenting Gram-negative pathogens isolated from cystic fibrosis patients.

Díez-Aguilar M, Ekkelenkamp M, Morosini MI, Merino I, de Dios Caballero J, Jones M, van Westreenen M, Tunney MM, Cantón R, Fluit AC.

Int J Antimicrob Agents. 2019 Jan;53(1):84-88. doi: 10.1016/j.ijantimicag.2018.09.001. Epub 2018 Sep 19.

PMID:
30240837
15.

Changes in bacterial hospital epidemiology.

Morosini MI, Cantón R.

Rev Esp Quimioter. 2018 Sep;31 Suppl 1:23-26. Review.

16.

First Report of an OXA-48- and CTX-M-213-Producing Kluyvera Species Clone Recovered from Patients Admitted in a University Hospital in Madrid, Spain.

Hernández-García M, León-Sampedro R, Pérez-Viso B, Morosini MI, López-Fresneña N, Díaz-Agero C, Coque TM, Ruiz-Garbajosa P, Cantón R.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01238-18. doi: 10.1128/AAC.01238-18. Print 2018 Nov.

17.

Performance of CHROMID® Colistin R agar, a new chromogenic medium for screening of colistin-resistant Enterobacterales.

García-Fernández S, García-Castillo M, Ruiz-Garbajosa P, Morosini MI, Bala Y, Zambardi G, Cantón R.

Diagn Microbiol Infect Dis. 2019 Jan;93(1):1-4. doi: 10.1016/j.diagmicrobio.2018.07.008. Epub 2018 Aug 7.

PMID:
30097296
18.

Effect of induction therapy on peripheral blood lymphocytes after lung transplantation: A multicenter international study.

Coiffard B, Piloni D, Boucekine M, Morosini M, Meloni F, Kessler R, Reynaud-Gaubert M.

Transpl Immunol. 2018 Jun;48:47-54. doi: 10.1016/j.trim.2018.02.013. Epub 2018 Feb 21. No abstract available.

PMID:
29475091
19.

Susceptibility testing and detection of β-lactam resistance mechanisms in Enterobacteriaceae: a multicentre national proficiency study.

Díez-Aguilar M, Conejo MC, Morosini MI, Tormo Palop N, Gimeno C, Cantón R, Pascual Á.

Int J Antimicrob Agents. 2018 Apr;51(4):612-619. doi: 10.1016/j.ijantimicag.2017.12.008. Epub 2017 Dec 21.

PMID:
29274802
20.

Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.

Díez-Aguilar M, Morosini MI, Köksal E, Oliver A, Ekkelenkamp M, Cantón R.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01650-17. doi: 10.1128/AAC.01650-17. Print 2018 Jan.

21.

The endless increase of antibiotic resistance in Enterobacteriaceae and the activity of new compounds to face the challenge.

Morosini MI.

Enferm Infecc Microbiol Clin. 2017 Oct;35(8):477-479. doi: 10.1016/j.eimc.2017.08.007. English, Spanish. No abstract available.

PMID:
28964321
22.

Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients.

Piloni D, Morosini M, Magni S, Balderacchi A, Scudeller L, Cova E, Oggionni T, Stella G, Tinelli C, Antonacci F, D'Armini AM, Meloni F.

BMC Pulm Med. 2017 Jul 18;17(1):102. doi: 10.1186/s12890-017-0446-y.

23.

Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents.

Cova E, Inghilleri S, Pandolfi L, Morosini M, Magni S, Colombo M, Piloni D, Finetti C, Ceccarelli G, Benedetti L, Cusella MG, Agozzino M, Corsi F, Allevi R, Mrakic-Sposta S, Moretti S, De Gregori S, Prosperi D, Meloni F.

Nanotoxicology. 2017 May;11(4):534-545. doi: 10.1080/17435390.2017.1317862. Epub 2017 Apr 27.

PMID:
28415888
24.

Reviewing the Brazilian National Primary Healthcare Policy at such a time?

Morosini MV, Fonseca AF.

Cad Saude Publica. 2017 Feb 13;33(1):e00206316. doi: 10.1590/0102-311X00206316. English, Portuguese. No abstract available.

25.

Bioequivalence of a New Oral Levosulpiride Formulation Compared With a Standard One in Healthy Volunteers.

De Gregori S, Cipollina L, De Silvestri A, Ventura M, Michelini R, Morosini M, Montagna M, Tinelli C, Regazzi M, Molinaro M, Imberti R.

Ther Drug Monit. 2017 Apr;39(2):118-123. doi: 10.1097/FTD.0000000000000380.

PMID:
28196046
26.

[Dalbavancin breakpoints and recommendations for in vitro study of its activity].

Cantón R, Díez-Aguilar M, Morosini MI.

Enferm Infecc Microbiol Clin. 2017 Jan;35 Suppl 1:15-21. doi: 10.1016/S0213-005X(17)30030-7. Spanish.

PMID:
28129815
27.

CHROMagar mSuperCARBA performance in carbapenem-resistant Enterobacteriaceae isolates characterized at molecular level and routine surveillance rectal swab specimens.

García-Fernández S, Hernández-García M, Valverde A, Ruiz-Garbajosa P, Morosini MI, Cantón R.

Diagn Microbiol Infect Dis. 2017 Mar;87(3):207-209. doi: 10.1016/j.diagmicrobio.2016.11.014. Epub 2016 Nov 25.

PMID:
27916545
28.

An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe.

Ruttens D, Verleden SE, Bijnens EM, Winckelmans E, Gottlieb J, Warnecke G, Meloni F, Morosini M, Van Der Bij W, Verschuuren EA, Sommerwerck U, Weinreich G, Kamler M, Roman A, Gomez-Olles S, Berastegui C, Benden C, Holm AM, Iversen M, Schultz HH, Luijk B, Oudijk EJ, Kwakkel-van Erp JM, Jaksch P, Klepetko W, Kneidinger N, Neurohr C, Corris P, Fisher AJ, Lordan J, Meachery G, Piloni D, Vandermeulen E, Bellon H, Hoffmann B, Vienneau D, Hoek G, de Hoogh K, Nemery B, Verleden GM, Vos R, Nawrot TS, Vanaudenaerde BM.

Eur Respir J. 2017 Jan 18;49(1). pii: 1600484. doi: 10.1183/13993003.00484-2016. Print 2017 Jan.

29.

Gut eradication of VIM-1 producing ST9 Klebsiella oxytoca after fecal microbiota transplantation for diarrhea caused by a Clostridium difficile hypervirulent R027 strain.

García-Fernández S, Morosini MI, Cobo M, Foruny JR, López-Sanromán A, Cobo J, Romero J, Cantón R, Del Campo R.

Diagn Microbiol Infect Dis. 2016 Dec;86(4):470-471. doi: 10.1016/j.diagmicrobio.2016.09.004. Epub 2016 Sep 16.

PMID:
27712927
30.

Etest® versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: results from PREMIUM, a European multicentre study.

Cantón R, Livermore DM, Morosini MI, Díaz-Regañón J, Rossolini GM; PREMIUM Study Group.

J Antimicrob Chemother. 2017 Feb;72(2):431-436. doi: 10.1093/jac/dkw442. Epub 2016 Oct 20.

31.

First description of late recurrence of catheter-associated bacteraemia due to Cellulosimicrobium cellulans.

Ponce-Alonso M, Del Campo R, Fortun J, Cantón R, Morosini MI.

Enferm Infecc Microbiol Clin. 2017 Feb;35(2):131-133. doi: 10.1016/j.eimc.2016.05.003. Epub 2016 Jun 8. No abstract available.

PMID:
27289255
32.

Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients.

Piloni D, Magni S, Oggionni T, Benazzo A, Stella G, Scudeller L, Morosini M, Cova E, Meloni F.

Transpl Immunol. 2016 Jul;37:35-39. doi: 10.1016/j.trim.2016.04.001. Epub 2016 Apr 16.

PMID:
27095000
33.

Emergence of cfr-Mediated Linezolid Resistance in a Methicillin-Resistant Staphylococcus aureus Epidemic Clone Isolated from Patients with Cystic Fibrosis.

de Dios Caballero J, Pastor MD, Vindel A, Máiz L, Yagüe G, Salvador C, Cobo M, Morosini MI, del Campo R, Cantón R; GEIFQ Study Group.

Antimicrob Agents Chemother. 2015 Dec 14;60(3):1878-82. doi: 10.1128/AAC.02067-15.

34.

Is a New Standard Needed for Diffusion Methods for In Vitro Susceptibility Testing of Fosfomycin against Pseudomonas aeruginosa?

Díez-Aguilar M, Martínez-García L, Cantón R, Morosini MI.

Antimicrob Agents Chemother. 2015 Dec 7;60(2):1158-61. doi: 10.1128/AAC.02237-15. Print 2016 Feb.

35.

Detection of Carbapenemase Production in a Collection of Enterobacteriaceae with Characterized Resistance Mechanisms from Clinical and Environmental Origins by Use of Both Carba NP and Blue-Carba Tests.

García-Fernández S, Morosini MI, Gijón D, Beatobe L, Ruiz-Garbajosa P, Domínguez L, Cantón R, Valverde A.

J Clin Microbiol. 2016 Feb;54(2):464-6. doi: 10.1128/JCM.02580-15. Epub 2015 Nov 25.

36.

Comparison of different methods for identification of species of the genus Raoultella: report of 11 cases of Raoultella causing bacteraemia and literature review.

Ponce-Alonso M, Rodríguez-Rojas L, Del Campo R, Cantón R, Morosini MI.

Clin Microbiol Infect. 2016 Mar;22(3):252-7. doi: 10.1016/j.cmi.2015.10.035. Epub 2015 Nov 11. Review.

37.

T-lymphocyte subsets in lung transplant recipients: association between nadir CD4 T-cell count and viral infections after transplantation.

Calarota SA, Chiesa A, De Silvestri A, Morosini M, Oggionni T, Marone P, Meloni F, Baldanti F.

J Clin Virol. 2015 Aug;69:110-6. doi: 10.1016/j.jcv.2015.06.078. Epub 2015 Jun 17.

PMID:
26209391
38.

Antimicrobial Activity of Fosfomycin-Tobramycin Combination against Pseudomonas aeruginosa Isolates Assessed by Time-Kill Assays and Mutant Prevention Concentrations.

Díez-Aguilar M, Morosini MI, Tedim AP, Rodríguez I, Aktaş Z, Cantón R.

Antimicrob Agents Chemother. 2015 Oct;59(10):6039-45. doi: 10.1128/AAC.00822-15. Epub 2015 Jul 20.

39.

Long-Term Off-Line Extracorporeal Photochemotherapy in Patients with Chronic Lung Allograft Rejection Not Responsive to Conventional Treatment: A 10-Year Single-Centre Analysis.

Del Fante C, Scudeller L, Oggionni T, Viarengo G, Cemmi F, Morosini M, Cascina A, Meloni F, Perotti C.

Respiration. 2015;90(2):118-28. doi: 10.1159/000431382. Epub 2015 Jun 20.

40.

Performance of EUCAST and CLSI approaches for co-amoxiclav susceptibility testing conditions for clinical categorization of a collection of Escherichia coli isolates with characterized resistance phenotypes.

Díez-Aguilar M, Morosini MI, López-Cerero L, Pascual Á, Calvo J, Martínez-Martínez L, Marco F, Vila J, Ortega A, Oteo J, Cantón R.

J Antimicrob Chemother. 2015 Aug;70(8):2306-10. doi: 10.1093/jac/dkv088. Epub 2015 Apr 21.

PMID:
25900161
41.

In vitro activity of ceftazidime, ceftaroline and aztreonam alone and in combination with avibactam against European Gram-negative and Gram-positive clinical isolates.

Testa R, Cantón R, Giani T, Morosini MI, Nichols WW, Seifert H, Stefanik D, Rossolini GM, Nordmann P.

Int J Antimicrob Agents. 2015 Jun;45(6):641-6. doi: 10.1016/j.ijantimicag.2014.12.033. Epub 2015 Feb 17.

PMID:
25748553
42.

Breakpoints for carbapenemase-producing Enterobacteriaceae: is the problem solved?

Cantón R, Canut A, Morosini MI, Oliver A.

Enferm Infecc Microbiol Clin. 2014 Dec;32 Suppl 4:33-40. doi: 10.1016/S0213-005X(14)70172-7. Review.

PMID:
25542050
43.

Evaluation of the eazyplex® SuperBug CRE system for rapid detection of carbapenemases and ESBLs in clinical Enterobacteriaceae isolates recovered at two Spanish hospitals.

García-Fernández S, Morosini MI, Marco F, Gijón D, Vergara A, Vila J, Ruiz-Garbajosa P, Cantón R.

J Antimicrob Chemother. 2015 Apr;70(4):1047-50. doi: 10.1093/jac/dku476. Epub 2014 Nov 26.

PMID:
25428926
44.

Evaluation of a loop-mediated isothermal amplification-based methodology to detect carbapenemase carriage in Acinetobacter clinical isolates.

Vergara A, Zboromyrska Y, Mosqueda N, Morosini MI, García-Fernández S, Roca I, Cantón R, Marco F, Vila J.

Antimicrob Agents Chemother. 2014 Dec;58(12):7538-40. doi: 10.1128/AAC.03870-14. Epub 2014 Sep 15.

45.

[Antimicrobial spectrum of ceftaroline. In vitro activity against methicillin-resistant staphylococci].

Cercenado E, Morosini MI.

Enferm Infecc Microbiol Clin. 2014 Mar;32 Suppl 2:8-14. doi: 10.1016/S0213-005X(14)70152-1. Spanish.

PMID:
24702973
46.

Rapid detection of β-lactamase-hydrolyzing extended-spectrum cephalosporins in Enterobacteriaceae by use of the new chromogenic βLacta test.

Morosini MI, García-Castillo M, Tato M, Gijón D, Valverde A, Ruiz-Garbajosa P, Cantón R.

J Clin Microbiol. 2014 May;52(5):1741-4. doi: 10.1128/JCM.03614-13. Epub 2014 Feb 26.

47.

Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction.

Cova E, Colombo M, Inghilleri S, Morosini M, Miserere S, Peñaranda-Avila J, Santini B, Piloni D, Magni S, Gramatica F, Prosperi D, Meloni F.

Nanomedicine (Lond). 2015 Jan;10(1):9-23. doi: 10.2217/nnm.13.208. Epub 2014 Feb 21.

PMID:
24559038
48.

Characterization of variables that may influence ozenoxacin in susceptibility testing, including MIC and MBC values.

Tato M, López Y, Morosini MI, Moreno-Bofarull A, Garcia-Alonso F, Gargallo-Viola D, Vila J, Cantón R.

Diagn Microbiol Infect Dis. 2014 Mar;78(3):263-7. doi: 10.1016/j.diagmicrobio.2013.11.010. Epub 2013 Nov 15.

PMID:
24321353
49.

Melioidosis in traveler from Africa to Spain.

Morosini MI, Quereda C, Gil H, Anda P, Núñez-Murga M, Cantón R, López-Vélez R.

Emerg Infect Dis. 2013 Oct;19(10):1656-9. doi: 10.3201/eid1910.121785.

50.

In vitro activity of fosfomycin against a collection of clinical Pseudomonas aeruginosa isolates from 16 Spanish hospitals: establishing the validity of standard broth microdilution as susceptibility testing method.

Díez-Aguilar M, Morosini MI, del Campo R, García-Castillo M, Zamora J, Cantón R.

Antimicrob Agents Chemother. 2013 Nov;57(11):5701-3. doi: 10.1128/AAC.00589-13. Epub 2013 Aug 12.

Supplemental Content

Loading ...
Support Center